Synthace Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$34.6M
- Investors
-
21
Synthace General Information
Description
Developer of a laboratory automation platform designed to reshape biological experimentation. The company's platform removes the wrangling of lab data through the dynamic generation, capture, and structuring of data with metadata, connects the experiment with other tools in the digital ecosystem, and helps to plan and execute multifactorial experiments, enabling biologists to conduct codeless reprogramming of liquid handlers and visual stimulation before executing experiments.
Contact Information
Website
www.synthace.comCorporate Office
- The Westworks
- 195 Wood Lane, 1th Floor
- London W12 7FQ
- England, United Kingdom
Corporate Office
- The Westworks
- 195 Wood Lane, 1th Floor
- London W12 7FQ
- England, United Kingdom
Synthace Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC (Series C) | 16-Nov-2021 | $34.6M | Completed | Generating Revenue | ||
| 12. Accelerator/Incubator | 23-Jan-2019 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series B) | 12-Dec-2018 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 01-Jun-2018 | Completed | Generating Revenue | |||
| 9. Grant | 01-Dec-2017 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A) | 01-Sep-2017 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 01-Dec-2016 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 01-Dec-2014 | Completed | Generating Revenue | |||
| 5. Seed Round | 24-Sep-2013 | $2.07M | $3.02M | Completed | Generating Revenue | |
| 4. Angel (individual) | 12-Apr-2013 | $944K | Completed | Generating Revenue |
Synthace Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C2 Preferred | ||||||||
| Series C1 Preferred | ||||||||
| Ordinary | ||||||||
| Series B | ||||||||
| 2017 Convertible Preference | ||||||||
| Ordinary | ||||||||
| 2017 Convertible Preference | ||||||||
| 2017 Convertible Preference | ||||||||
| Convertible Preference | 3,796,414 | $0.001363 | $0.68 | $0.68 | 1x | $0.68 | 4.84% | |
| Ordinary | 652,261 | $0.001363 | $0.68 | $0.68 | 3x | $0.68 | 0.83% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Synthace Comparisons
Industry
Financing
Details
Synthace Competitors (7)
One of Synthace’s 7 competitors is SnapGene, a Formerly PE-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SnapGene | Formerly PE-Backed | Boston, MA | ||||
| TetraScience | Venture Capital-Backed | Boston, MA | ||||
| Tempus AI | Formerly VC-backed | Chicago, IL | ||||
| Owkin | Venture Capital-Backed | Paris, France | ||||
| Benchling | Venture Capital-Backed | San Francisco, CA |
Synthace Patents
Synthace Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202307650-D0 | Systems and method for integration of generative artificial intelligence with desing and automation of expriments | Inactive | 22-May-2023 | ||
| GB-202404764-D0 | Accessible active learning and llms to enable faster iteration in process development and r&d | Inactive | 14-Apr-2023 | ||
| GB-202305498-D0 | Methods for optimisation of liquid handling processes | Inactive | 14-Apr-2023 | ||
| WO-2024213903-A1 | Methods for optimisation of liquid handling processes | Inactive | 14-Apr-2023 | ||
| EP-4085257-A1 | Systems and methods for improved automation of laboratory processes | Active | 31-Dec-2019 | G01N35/0092 |
Synthace Signals
Synthace Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Razor Capital | Venture Capital | Minority | ||
| Plug and Play | Accelerator/Incubator | |||
| Startup Creasphere | Accelerator/Incubator | Minority | ||
| ICONIQ Growth | Venture Capital | Minority |
Synthace FAQs
-
When was Synthace founded?
Synthace was founded in 2011.
-
Where is Synthace headquartered?
Synthace is headquartered in London, United Kingdom.
-
What is the size of Synthace?
Synthace has 37 total employees.
-
What industry is Synthace in?
Synthace’s primary industry is Enterprise Systems (Healthcare).
-
Is Synthace a private or public company?
Synthace is a Private company.
-
What is the current valuation of Synthace?
The current valuation of Synthace is .
-
What is Synthace’s current revenue?
The current revenue for Synthace is .
-
How much funding has Synthace raised over time?
Synthace has raised $89.2M.
-
Who are Synthace’s investors?
, Razor Capital, Plug and Play, Startup Creasphere, and ICONIQ Growth are 5 of 21 investors who have invested in Synthace.
-
Who are Synthace’s competitors?
SnapGene, TetraScience, Tempus AI, Owkin, and Benchling are some of the 7 competitors of Synthace.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process